ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Leflunomide Tablets Market Research Report 2024
Published Date: September 2024
|
Report Code: QYRE-Auto-31N18044
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Leflunomide Tablets Market Research Report 2024
BUY CHAPTERS

Global Leflunomide Tablets Market Research Report 2024

Code: QYRE-Auto-31N18044
Report
September 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Qilu Pharmaceutical Co. Ltd.
Meiro Pharmaceutical Co., Ltd.
Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
Changzhou Watson Pharmaceutical Co., Ltd.
Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
Hebei Wansui Pharmaceutical Co., Ltd.
Xiamen Lizhuo Pharmaceutical Co., Ltd.
Fujian Huitian Biopharmaceutical Co., Ltd.
Lupin Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Sanofi
Alembic Pharmaceuticals Inc.

Leflunomide Tablets Market

Leflunomide tablets are an immunosuppressant drug mainly used to treat autoimmune diseases, especially rheumatoid arthritis. It reduces inflammation, joint damage, and improves the patient's quality of life by inhibiting cell proliferation and immune response.
The global Leflunomide Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Leflunomide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Leflunomide Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Leflunomide Tablets include Qilu Pharmaceutical Co., Ltd., Meiro Pharmaceutical Co., Ltd., Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd., Changzhou Watson Pharmaceutical Co., Ltd., Jiangsu Yabang Epson Pharmaceutical Co., Ltd., Hebei Wansui Pharmaceutical Co., Ltd., Xiamen Lizhuo Pharmaceutical Co., Ltd., Fujian Huitian Biopharmaceutical Co., Ltd., Lupin Pharmaceuticals, Inc., Alembic Pharmaceuticals Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Leflunomide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leflunomide Tablets.
The Leflunomide Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Leflunomide Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Leflunomide Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Leflunomide Tablets Market Report

Report Metric Details
Report Name Leflunomide Tablets Market
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Qilu Pharmaceutical Co., Ltd., Meiro Pharmaceutical Co., Ltd., Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd., Changzhou Watson Pharmaceutical Co., Ltd., Jiangsu Yabang Epson Pharmaceutical Co., Ltd., Hebei Wansui Pharmaceutical Co., Ltd., Xiamen Lizhuo Pharmaceutical Co., Ltd., Fujian Huitian Biopharmaceutical Co., Ltd., Lupin Pharmaceuticals, Inc., Alembic Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sanofi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Leflunomide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Leflunomide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Leflunomide Tablets Market report?

Ans: The main players in the Leflunomide Tablets Market are Qilu Pharmaceutical Co., Ltd., Meiro Pharmaceutical Co., Ltd., Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd., Changzhou Watson Pharmaceutical Co., Ltd., Jiangsu Yabang Epson Pharmaceutical Co., Ltd., Hebei Wansui Pharmaceutical Co., Ltd., Xiamen Lizhuo Pharmaceutical Co., Ltd., Fujian Huitian Biopharmaceutical Co., Ltd., Lupin Pharmaceuticals, Inc., Alembic Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Sanofi

What are the Application segmentation covered in the Leflunomide Tablets Market report?

Ans: The Applications covered in the Leflunomide Tablets Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Leflunomide Tablets Market report?

Ans: The Types covered in the Leflunomide Tablets Market report are Generic Drugs, Original Drugs

Recommended Reports

Autoimmune & Immunosuppressants

Tablet Pharmaceuticals

Chronic Disease Drugs

1 Leflunomide Tablets Market Overview
1.1 Product Definition
1.2 Leflunomide Tablets by Type
1.2.1 Global Leflunomide Tablets Market Value Comparison by Type (2024-2030)
1.2.2 Generic Drugs
1.2.3 Original Drugs
1.3 Leflunomide Tablets by Application
1.3.1 Global Leflunomide Tablets Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Leflunomide Tablets Market Size Estimates and Forecasts
1.4.1 Global Leflunomide Tablets Revenue 2019-2030
1.4.2 Global Leflunomide Tablets Sales 2019-2030
1.4.3 Global Leflunomide Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Leflunomide Tablets Market Competition by Manufacturers
2.1 Global Leflunomide Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Leflunomide Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Leflunomide Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Leflunomide Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Leflunomide Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Leflunomide Tablets, Product Type & Application
2.7 Global Key Manufacturers of Leflunomide Tablets, Date of Enter into This Industry
2.8 Global Leflunomide Tablets Market Competitive Situation and Trends
2.8.1 Global Leflunomide Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Leflunomide Tablets Players Market Share by Revenue
2.8.3 Global Leflunomide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Leflunomide Tablets Market Scenario by Region
3.1 Global Leflunomide Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Leflunomide Tablets Sales by Region: 2019-2030
3.2.1 Global Leflunomide Tablets Sales by Region: 2019-2024
3.2.2 Global Leflunomide Tablets Sales by Region: 2025-2030
3.3 Global Leflunomide Tablets Revenue by Region: 2019-2030
3.3.1 Global Leflunomide Tablets Revenue by Region: 2019-2024
3.3.2 Global Leflunomide Tablets Revenue by Region: 2025-2030
3.4 North America Leflunomide Tablets Market Facts & Figures by Country
3.4.1 North America Leflunomide Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Leflunomide Tablets Sales by Country (2019-2030)
3.4.3 North America Leflunomide Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Leflunomide Tablets Market Facts & Figures by Country
3.5.1 Europe Leflunomide Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Leflunomide Tablets Sales by Country (2019-2030)
3.5.3 Europe Leflunomide Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Leflunomide Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Leflunomide Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Leflunomide Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Leflunomide Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Leflunomide Tablets Market Facts & Figures by Country
3.7.1 Latin America Leflunomide Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Leflunomide Tablets Sales by Country (2019-2030)
3.7.3 Latin America Leflunomide Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Leflunomide Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Leflunomide Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Leflunomide Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Leflunomide Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Leflunomide Tablets Sales by Type (2019-2030)
4.1.1 Global Leflunomide Tablets Sales by Type (2019-2024)
4.1.2 Global Leflunomide Tablets Sales by Type (2025-2030)
4.1.3 Global Leflunomide Tablets Sales Market Share by Type (2019-2030)
4.2 Global Leflunomide Tablets Revenue by Type (2019-2030)
4.2.1 Global Leflunomide Tablets Revenue by Type (2019-2024)
4.2.2 Global Leflunomide Tablets Revenue by Type (2025-2030)
4.2.3 Global Leflunomide Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Leflunomide Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Leflunomide Tablets Sales by Application (2019-2030)
5.1.1 Global Leflunomide Tablets Sales by Application (2019-2024)
5.1.2 Global Leflunomide Tablets Sales by Application (2025-2030)
5.1.3 Global Leflunomide Tablets Sales Market Share by Application (2019-2030)
5.2 Global Leflunomide Tablets Revenue by Application (2019-2030)
5.2.1 Global Leflunomide Tablets Revenue by Application (2019-2024)
5.2.2 Global Leflunomide Tablets Revenue by Application (2025-2030)
5.2.3 Global Leflunomide Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Leflunomide Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Qilu Pharmaceutical Co., Ltd.
6.1.1 Qilu Pharmaceutical Co., Ltd. Company Information
6.1.2 Qilu Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
6.1.5 Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 Meiro Pharmaceutical Co., Ltd.
6.2.1 Meiro Pharmaceutical Co., Ltd. Company Information
6.2.2 Meiro Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
6.2.5 Meiro Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
6.3.1 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Company Information
6.3.2 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
6.3.5 Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Changzhou Watson Pharmaceutical Co., Ltd.
6.4.1 Changzhou Watson Pharmaceutical Co., Ltd. Company Information
6.4.2 Changzhou Watson Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
6.4.5 Changzhou Watson Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
6.5.1 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information
6.5.2 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
6.5.5 Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Hebei Wansui Pharmaceutical Co., Ltd.
6.6.1 Hebei Wansui Pharmaceutical Co., Ltd. Company Information
6.6.2 Hebei Wansui Pharmaceutical Co., Ltd. Description and Business Overview
6.6.3 Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
6.6.5 Hebei Wansui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.7 Xiamen Lizhuo Pharmaceutical Co., Ltd.
6.7.1 Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information
6.7.2 Xiamen Lizhuo Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
6.7.5 Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Fujian Huitian Biopharmaceutical Co., Ltd.
6.8.1 Fujian Huitian Biopharmaceutical Co., Ltd. Company Information
6.8.2 Fujian Huitian Biopharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Product Portfolio
6.8.5 Fujian Huitian Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Lupin Pharmaceuticals, Inc.
6.9.1 Lupin Pharmaceuticals, Inc. Company Information
6.9.2 Lupin Pharmaceuticals, Inc. Description and Business Overview
6.9.3 Lupin Pharmaceuticals, Inc. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lupin Pharmaceuticals, Inc. Leflunomide Tablets Product Portfolio
6.9.5 Lupin Pharmaceuticals, Inc. Recent Developments/Updates
6.10 Alembic Pharmaceuticals Inc.
6.10.1 Alembic Pharmaceuticals Inc. Company Information
6.10.2 Alembic Pharmaceuticals Inc. Description and Business Overview
6.10.3 Alembic Pharmaceuticals Inc. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Alembic Pharmaceuticals Inc. Leflunomide Tablets Product Portfolio
6.10.5 Alembic Pharmaceuticals Inc. Recent Developments/Updates
6.11 Teva Pharmaceutical Industries Ltd.
6.11.1 Teva Pharmaceutical Industries Ltd. Company Information
6.11.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.11.3 Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Product Portfolio
6.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.12 Sanofi
6.12.1 Sanofi Company Information
6.12.2 Sanofi Description and Business Overview
6.12.3 Sanofi Leflunomide Tablets Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Sanofi Leflunomide Tablets Product Portfolio
6.12.5 Sanofi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Leflunomide Tablets Industry Chain Analysis
7.2 Leflunomide Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Leflunomide Tablets Production Mode & Process
7.4 Leflunomide Tablets Sales and Marketing
7.4.1 Leflunomide Tablets Sales Channels
7.4.2 Leflunomide Tablets Distributors
7.5 Leflunomide Tablets Customers
8 Leflunomide Tablets Market Dynamics
8.1 Leflunomide Tablets Industry Trends
8.2 Leflunomide Tablets Market Drivers
8.3 Leflunomide Tablets Market Challenges
8.4 Leflunomide Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Qilu Pharmaceutical Co. Ltd.
Meiro Pharmaceutical Co., Ltd.
Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd.
Changzhou Watson Pharmaceutical Co., Ltd.
Jiangsu Yabang Epson Pharmaceutical Co., Ltd.
Hebei Wansui Pharmaceutical Co., Ltd.
Xiamen Lizhuo Pharmaceutical Co., Ltd.
Fujian Huitian Biopharmaceutical Co., Ltd.
Lupin Pharmaceuticals, Inc
Teva Pharmaceutical Industries Ltd
Sanofi
Alembic Pharmaceuticals Inc.
List of Tables
 Table 1. Global Leflunomide Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Leflunomide Tablets Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Leflunomide Tablets Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Leflunomide Tablets Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Leflunomide Tablets Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Leflunomide Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Leflunomide Tablets Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Leflunomide Tablets Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Leflunomide Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Leflunomide Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Leflunomide Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Leflunomide Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Leflunomide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leflunomide Tablets as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Leflunomide Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Leflunomide Tablets Sales by Region (2019-2024) & (K Units)
 Table 18. Global Leflunomide Tablets Sales Market Share by Region (2019-2024)
 Table 19. Global Leflunomide Tablets Sales by Region (2025-2030) & (K Units)
 Table 20. Global Leflunomide Tablets Sales Market Share by Region (2025-2030)
 Table 21. Global Leflunomide Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Leflunomide Tablets Revenue Market Share by Region (2019-2024)
 Table 23. Global Leflunomide Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Leflunomide Tablets Revenue Market Share by Region (2025-2030)
 Table 25. North America Leflunomide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Leflunomide Tablets Sales by Country (2019-2024) & (K Units)
 Table 27. North America Leflunomide Tablets Sales by Country (2025-2030) & (K Units)
 Table 28. North America Leflunomide Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Leflunomide Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Leflunomide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Leflunomide Tablets Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Leflunomide Tablets Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Leflunomide Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Leflunomide Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Leflunomide Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Leflunomide Tablets Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Leflunomide Tablets Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Leflunomide Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Leflunomide Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Leflunomide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Leflunomide Tablets Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Leflunomide Tablets Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Leflunomide Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Leflunomide Tablets Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Leflunomide Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Leflunomide Tablets Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Leflunomide Tablets Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Leflunomide Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Leflunomide Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Leflunomide Tablets Sales (K Units) by Type (2019-2024)
 Table 51. Global Leflunomide Tablets Sales (K Units) by Type (2025-2030)
 Table 52. Global Leflunomide Tablets Sales Market Share by Type (2019-2024)
 Table 53. Global Leflunomide Tablets Sales Market Share by Type (2025-2030)
 Table 54. Global Leflunomide Tablets Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Leflunomide Tablets Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Leflunomide Tablets Revenue Market Share by Type (2019-2024)
 Table 57. Global Leflunomide Tablets Revenue Market Share by Type (2025-2030)
 Table 58. Global Leflunomide Tablets Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Leflunomide Tablets Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Leflunomide Tablets Sales (K Units) by Application (2019-2024)
 Table 61. Global Leflunomide Tablets Sales (K Units) by Application (2025-2030)
 Table 62. Global Leflunomide Tablets Sales Market Share by Application (2019-2024)
 Table 63. Global Leflunomide Tablets Sales Market Share by Application (2025-2030)
 Table 64. Global Leflunomide Tablets Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Leflunomide Tablets Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Leflunomide Tablets Revenue Market Share by Application (2019-2024)
 Table 67. Global Leflunomide Tablets Revenue Market Share by Application (2025-2030)
 Table 68. Global Leflunomide Tablets Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Leflunomide Tablets Price (US$/Unit) by Application (2025-2030)
 Table 70. Qilu Pharmaceutical Co., Ltd. Company Information
 Table 71. Qilu Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Qilu Pharmaceutical Co., Ltd. Leflunomide Tablets Product
 Table 74. Qilu Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. Meiro Pharmaceutical Co., Ltd. Company Information
 Table 76. Meiro Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Meiro Pharmaceutical Co., Ltd. Leflunomide Tablets Product
 Table 79. Meiro Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Company Information
 Table 81. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Leflunomide Tablets Product
 Table 84. Suzhou Changzheng-Xinkai Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Changzhou Watson Pharmaceutical Co., Ltd. Company Information
 Table 86. Changzhou Watson Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Changzhou Watson Pharmaceutical Co., Ltd. Leflunomide Tablets Product
 Table 89. Changzhou Watson Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Company Information
 Table 91. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Leflunomide Tablets Product
 Table 94. Jiangsu Yabang Epson Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. Hebei Wansui Pharmaceutical Co., Ltd. Company Information
 Table 96. Hebei Wansui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 97. Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Hebei Wansui Pharmaceutical Co., Ltd. Leflunomide Tablets Product
 Table 99. Hebei Wansui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 100. Xiamen Lizhuo Pharmaceutical Co., Ltd. Company Information
 Table 101. Xiamen Lizhuo Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Xiamen Lizhuo Pharmaceutical Co., Ltd. Leflunomide Tablets Product
 Table 104. Xiamen Lizhuo Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. Fujian Huitian Biopharmaceutical Co., Ltd. Company Information
 Table 106. Fujian Huitian Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 107. Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Fujian Huitian Biopharmaceutical Co., Ltd. Leflunomide Tablets Product
 Table 109. Fujian Huitian Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. Lupin Pharmaceuticals, Inc. Company Information
 Table 111. Lupin Pharmaceuticals, Inc. Description and Business Overview
 Table 112. Lupin Pharmaceuticals, Inc. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Lupin Pharmaceuticals, Inc. Leflunomide Tablets Product
 Table 114. Lupin Pharmaceuticals, Inc. Recent Developments/Updates
 Table 115. Alembic Pharmaceuticals Inc. Company Information
 Table 116. Alembic Pharmaceuticals Inc. Description and Business Overview
 Table 117. Alembic Pharmaceuticals Inc. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 118. Alembic Pharmaceuticals Inc. Leflunomide Tablets Product
 Table 119. Alembic Pharmaceuticals Inc. Recent Developments/Updates
 Table 120. Teva Pharmaceutical Industries Ltd. Company Information
 Table 121. Teva Pharmaceutical Industries Ltd. Description and Business Overview
 Table 122. Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 123. Teva Pharmaceutical Industries Ltd. Leflunomide Tablets Product
 Table 124. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 125. Sanofi Company Information
 Table 126. Sanofi Description and Business Overview
 Table 127. Sanofi Leflunomide Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 128. Sanofi Leflunomide Tablets Product
 Table 129. Sanofi Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Leflunomide Tablets Distributors List
 Table 133. Leflunomide Tablets Customers List
 Table 134. Leflunomide Tablets Market Trends
 Table 135. Leflunomide Tablets Market Drivers
 Table 136. Leflunomide Tablets Market Challenges
 Table 137. Leflunomide Tablets Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Leflunomide Tablets
 Figure 2. Global Leflunomide Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Leflunomide Tablets Market Share by Type: 2023 & 2030
 Figure 4. Generic Drugs Product Picture
 Figure 5. Original Drugs Product Picture
 Figure 6. Global Leflunomide Tablets Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Leflunomide Tablets Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Leflunomide Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Leflunomide Tablets Market Size (2019-2030) & (US$ Million)
 Figure 13. Global Leflunomide Tablets Sales (2019-2030) & (K Units)
 Figure 14. Global Leflunomide Tablets Average Price (US$/Unit) & (2019-2030)
 Figure 15. Leflunomide Tablets Report Years Considered
 Figure 16. Leflunomide Tablets Sales Share by Manufacturers in 2023
 Figure 17. Global Leflunomide Tablets Revenue Share by Manufacturers in 2023
 Figure 18. Global 5 and 10 Largest Leflunomide Tablets Players: Market Share by Revenue in Leflunomide Tablets in 2023
 Figure 19. Leflunomide Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 20. Global Leflunomide Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 21. North America Leflunomide Tablets Sales Market Share by Country (2019-2030)
 Figure 22. North America Leflunomide Tablets Revenue Market Share by Country (2019-2030)
 Figure 23. United States Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 24. Canada Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Europe Leflunomide Tablets Sales Market Share by Country (2019-2030)
 Figure 26. Europe Leflunomide Tablets Revenue Market Share by Country (2019-2030)
 Figure 27. Germany Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 28. France Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. U.K. Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. Italy Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Russia Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Asia Pacific Leflunomide Tablets Sales Market Share by Region (2019-2030)
 Figure 33. Asia Pacific Leflunomide Tablets Revenue Market Share by Region (2019-2030)
 Figure 34. China Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 35. Japan Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. South Korea Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. India Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. Australia Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. China Taiwan Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Southeast Asia Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Latin America Leflunomide Tablets Sales Market Share by Country (2019-2030)
 Figure 42. Mexico Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Brazil Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Argentina Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Colombia Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Middle East and Africa Leflunomide Tablets Sales Market Share by Country (2019-2030)
 Figure 47. Middle East and Africa Leflunomide Tablets Revenue Market Share by Country (2019-2030)
 Figure 48. Turkey Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 49. Saudi Arabia Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. UAE Leflunomide Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Global Sales Market Share of Leflunomide Tablets by Type (2019-2030)
 Figure 52. Global Revenue Market Share of Leflunomide Tablets by Type (2019-2030)
 Figure 53. Global Leflunomide Tablets Price (US$/Unit) by Type (2019-2030)
 Figure 54. Global Sales Market Share of Leflunomide Tablets by Application (2019-2030)
 Figure 55. Global Revenue Market Share of Leflunomide Tablets by Application (2019-2030)
 Figure 56. Global Leflunomide Tablets Price (US$/Unit) by Application (2019-2030)
 Figure 57. Leflunomide Tablets Value Chain
 Figure 58. Leflunomide Tablets Production Process
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Leflunomide Market Research Report 2025
Global Diflunisal Tablets Market Research Report 2024
Global Teriflunomide Market Research Report 2024
Global Immunosuppressants Market Research Report 2024
Global Glimepiride Tablet Market Research Report 2024
Global Rufinamide Market Insights Forecast to 2030
Global Phenprobamate Tablets Market Research Report 2024
Global Anti Rheumatic Drugs Market Research Report 2024
Global Lornoxicam Tablets Market Research Report 2024
Global Ocular Immunosuppresents Market Research Report 2024
Global Leuprolide Market Research Report 2024
Global Ocular Immunosuppressants Market Research Report 2024
Global Apremilast Tablets Market Research Report 2024
Global Autoimmune Disease Drugs Market Research Report 2025
Global Phenylbutazone Tablets Market Research Report 2024
Global Pirfenidone Tablets Market Research Report 2024
Global Rosuvastatin Calcium Tablets Market Research Report 2024
Global Leuprorelin Drugs Market Research Report 2024
Global Colchicine Tablets Market Research Report 2024
Global Rheumatoid Arthritis RA Medications Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions